Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Hold
9,584
0.28% 40
2026
Q1
$1.15M Hold
9,584
0.42% 34
2025
Q4
$1.01M Sell
9,584
-3,000
-24% -$282K 0.37% 40
2025
Q3
$1.06M Hold
12,584
0.32% 46
2025
Q2
$996K Hold
12,584
0.35% 48
2025
Q1
$1.13M Buy
12,584
+4,200
+50% +$392K 0.48% 37
2024
Q4
$834K Buy
8,384
+964
+13% +$99.4K 0.53% 30
2024
Q3
$843K Hold
7,420
0.38% 27
2024
Q2
$919K Hold
7,420
0.44% 24
2024
Q1
$979K Hold
7,420
0.49% 23
2023
Q4
$809K Buy
7,420
+820
+12% +$85.1K 0.43% 23
2023
Q3
$679K Hold
6,600
0.39% 25
2023
Q2
$762K Hold
6,600
0.43% 23
2023
Q1
$702K Hold
6,600
0.42% 25
2022
Q4
$732K Hold
6,600
0.44% 26
2022
Q3
$568K Buy
+6,600
New +$589K 0.36% 27
2013
Q4
Sell
-590
Closed -$27K 65
2013
Q3
$27K Sell
590
-400
-40% -$18.3K 0.01% 57
2013
Q2
$44K Buy
+990
New +$44.2K 0.02% 65

Other funds holding MRK

Alta Advisers's MRK Position: Q2 2026 in Review

Alta Advisers held its Merck (MRK) position steady in Q2 2026 at 9,584 shares worth $1.23M. The position accounts for 0.28% of the portfolio, ranked #40.

Alta Advisers first reported a position in MRK in Q2 2013 and has held it in 18 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Alta Advisers held 9,584 shares of Merck worth $1.23M as of Q2 2026.
  • Alta Advisers left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.28% of Alta Advisers's portfolio in Q2 2026, its #40 holding.
  • Alta Advisers first reported a position in Merck in Q2 2013 and has held it in 18 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Alta Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.